Glaucoma

National Eye InstituteGlaucoma is a group of diseases of the optic nerve involving loss of retinal ganglion cells in a characteristic pattern of optic neuropathy. Although raised intraocular pressure is a significant risk factor for developing glaucoma, there is no set threshold for intraocular pressure that causes glaucoma. One person may develop nerve damage at a relatively low pressure, while another person may have high eye pressure for years and yet never develop damage. Untreated glaucoma leads to permanent damage of the optic nerve and resultant visual field loss, which can progress to blindness.Glaucoma has been nicknamed "the silent sight thief". Worldwide, it is the second leading cause of blindness. Glaucoma affects one in two hundred people aged fifty and younger and one in ten over the age of eighty. (From the Wikpedia article Glaucoma.)

Download PDF containing detailed information.

Recent Publications on Glaucoma:
Incidence of conjunctival exposure following drainage device implantation in patients with glaucoma. Purpose. To evaluate prior studies including a glaucoma drainage device...	21st November, 2009	PRN Pharmaceutical Research Network, LLC, Dallas, TX - USA.	Eur J Ophthalmol. 2009 Nov 5.
Course of intraocular pressure after intravitreal injection of 0.05 mL ranibizumab (Lucentis(R)). Purpose. This prospective study examines the changes in short-term...	21st November, 2009	Department of Ophthalmology, Ludwigshafen Hospital - Germany.	Eur J Ophthalmol. 2009 Nov 18.
The Prevalence and Causes of Visual Loss Among HIV-Infected Individuals With Visual Loss in Uganda. AIM:: To determine the prevalence of loss of visual acuity and to describe...	21st November, 2009	From the *Department of Ophthalmology, Mulago Hospital/Makerere	J Acquir Immune Defic Syndr. 2009 Nov 19. DOI Direct Link
Mitomycin C-augmented deep sclerectomy in primary open-angle glaucoma and exfoliation glaucoma: a three-year prospective study. Purpose: To investigate the efficacy and safety of mitomycin C...	21st November, 2009	Department of Ophthalmology, Kuopio University Hospital, Kuopio, Finland.	Acta Ophthalmol. 2009 Nov 19. DOI Direct Link
Macular thickness changes after phacoemulsification combined with primary posterior curvilinear capsulorhexis. Purpose. To evaluate the changes in central macular thickness measured...	20th November, 2009	Beyoglu Eye Training and Research Hospital, Istanbul - Turkey.	Eur J Ophthalmol. 2009 Nov 11.
→View more research publications.

Press Releases About Glaucoma:
deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court	24th November, 2009	DeCODE Genetics Inc	REYKJAVIK, Iceland, November 24 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq:DCGN) today announced the approval of all of its "first day" motions by the U.S. Bankruptcy Court
deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets	17th November, 2009	deCODE genetics	REYKJAVIK, Iceland, Nov. 17 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it has filed a voluntary petition for relief under Chapter 11 of the United States
Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development	26th October, 2009	Reportlinker	-- Prospects for ion channel modulators and commercial successes to date-- Pipeline activities, expert views, and survey results Ion Channel Modulator Pipelines: Targets and Agents in
World's Largest Ocular Research Center to Improve Quality of Life for Blind and Visually Impaired	7th October, 2009	Lions Eye Institute for Transplant & Research	Lions Eye Institute for Transplant & Research Sets Sights on Advances in Macular Degeneration and Glaucoma TAMPA, Fla., Oct. 7 /PRNewswire-USNewswire/ -- Real-time biomedical studies of factors
Recession Cutting Into Doctor Visits, According to New Consumer Survey	29th September, 2009	American Optometric Association	ST. LOUIS, Sept. 29 /PRNewswire/ -- While the economy begins to show signs of a slow recovery, many consumers continue to struggle with financial challenges, some of which could affect their health. A

BioNews Results for Glaucoma:
What is one cost-effective way of reducing visual loss from glaucoma in aging populations around the world?	OSN Super Site:  Nov 21 2009 3:55AM Matching: glaucoma
Continued advancements needed for best treatment of glaucoma	OSN Super Site:  Nov 21 2009 3:55AM Matching: glaucoma
Surgery as First Line Therapy for Glaucoma	OSN Super Site:  Nov 21 2009 3:55AM Matching: glaucoma
A glaucoma korszer gondozsa a XXI. szzad elejn	Bioscience Technology Online:  Nov 21 2009 6:42AM Matching: glaucoma
Travoprost: A prostaglandin analogue for the treatment of glaucoma	Formulary Journal:  Nov 21 2009 1:00AM Matching: glaucoma
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

Glaucoma Patents:
US Patent No.	Title
7608635	Pyrazole compounds that modulate HSP90 activity
7612080	GTPase inhibitors and use thereof for controlling platelet hyperactivity
7612082	Prostaglandin EP.sub.4 antagonists
7612101	Abnormal cannabidiols as agents for lowering intraocular pressure
7612115	Aqueous pharmaceutical compositions
→View more patents.

Companies working in the area of Glaucoma from Bioportfolio's Biocorporate database :
Company Name
ACADIA Pharmaceuticals ACADIA Pharmaceuticals is a drug discovery and development company that efficiently identifies target-specific small molecule drug candidates using its proprietary chemical-genomics platform. ACADIA's... www.acadia-pharm.com/        View full profile
Biospecifics Technologies Corporation A pharmaceutical company with a major focus on wound healing and tissue remodeling. Pioneering the application of Collagenase for the treatment of diseases. Dermal... www.biospecifics.com/        View full profile
Cambridge NeuroScience Incorporated Cambridge NeuroScience Incorporated is a biopharmaceutical company engaged in the discovery and development of proprietary pharmaceuticals to prevent or treat severe disorders of, or injuries to, the... www.cambneuro.com/        View full profile
→View more Glaucoma related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Glaucoma scientists - we have details of around 3922 individuals working on Glaucoma .